Framework agreement for oncology drugs
Original notice title
Romania – Antineoplastic and immunomodulating agents – Acord cadru medicamente oncologice 12 LOTURI
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Risk factors
Submission deadline in 9 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Award Criteria
Lot 1
Lot 2
Lot 3
Lot 4
Lot 5
Lot 6
Lot 7
Lot 8
Lot 9
Lot 10
Lot 11
Lot 12
Buyer
Name
Ministerul Apararii - U.M 02175 Constanta
Location
Constanta, ROU
Website
Buyer profile
Identifier
4301383
Activity
Health
Lots (12)
LOT-0001
SACITUZUMAB CONC. PT.SOL.PERF. 50ML/200MG
SACITUZUMAB GOVITECAN CONC. PT.SOL.PERF. 50ML/200MG cantitate minima acord cadru 10 cantitate maxima acord cadru 100
RON 482.1k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Framework maximum value
LOT-0002
AVELUMABUM CONC. PT. SOL. PERF. 20 mg /ml - 10 ml
AVELUMABUM CONC. PT. SOL. PERF. 20 mg /ml - 10 ml cantitate minima acord cadru 10 cantitate maxima acord cadru 50
RON 166k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Framework maximum value
LOT-0003
PEMBROLIZUMABUM CONC. PT. SOL. PERF. 25MG/ML - 4 ML (100 MG)
PEMBROLIZUMABUM CONC. PT. SOL. PERF. 25MG/ML - 4 ML (100 MG) cantitate minima acord cadru 10 cantitate maxima acord cadru 200
RON 2.2M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Framework maximum value
LOT-0004
TRASTUZUMABUM EMTAMSINUM PULB. PT. CONC. PT. SOL. PERF. 100MG/15 ML
TRASTUZUMABUM EMTAMSINUM PULB. PT. CONC. PT. SOL. PERF. 100MG/15 ML cantitate minima acord cadru 10 cantitate maxima acord cadru 200
RON 1.3M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Framework maximum value
LOT-0005
CEMIPLIMABUM CONC. PT.SOL.PERF. 50MG/ML - 70 ML (350,G)
CEMIPLIMABUM CONC. PT.SOL.PERF. 50MG/ML - 70 ML (350,G) cantitate minima acord cadru 10 cantitate maxima acord cadru 350
RON 5.5M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Framework maximum value
LOT-0006
BEVACIZUMABUM CONC. PT. SOL. PERF. 25MG/ML - 4 ML
BEVACIZUMABUM CONC. PT. SOL. PERF. 25MG/ML - 4 ML cantitate minima acord cadru 10 cantitate maxima acord cadru 300
RON 288.6k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Framework maximum value
LOT-0007
BEVACIZUMABUM CONC. PT. SOL. PERF. 25MG/ML - 16 ML
BEVACIZUMABUM CONC. PT. SOL. PERF. 25MG/ML - 16 ML cantitate minima acord cadru 10 cantitate maxima acord cadru 300
RON 1.2M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Framework maximum value
LOT-0008
RAMUCIRUMABUM CONC. PT. SOL. PERF. 10MG/ML - 10 ML
RAMUCIRUMABUM CONC. PT. SOL. PERF. 10MG/ML - 10 ML cantitate minima acord cadru 10 cantitate maxima acord cadru 100
RON 344.7k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Framework maximum value
LOT-0009
NIVOLUMABUM CONC. PT. SOL. PERF. 10MG/ML - 4 ML (40 MG)
NIVOLUMABUM CONC. PT. SOL. PERF. 10MG/ML - 4 ML (40 MG) cantitate minima acord cadru 10 cantitate maxima acord cadru 250
RON 489.5k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Framework maximum value
LOT-0010
NIVOLUMABUM CONC. PT. SOL. PERF. 10MG/ML - 10 ML (100 MG)
NIVOLUMABUM CONC. PT. SOL. PERF. 10MG/ML - 10 ML (100 MG) cantitate minima acord cadru 10 cantitate maxima acord cadru 300
RON 1.5M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Framework maximum value
LOT-0011
DURVALUMABUM CONC. PT. SOL. PERF. 50 MG / ML - 10 ML CONC
DURVALUMABUM CONC. PT. SOL. PERF. 50 MG / ML - 10 ML CONC cantitate minima acord cadru 4 cantitate maxima acord cadru 50
RON 425.9k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Framework maximum value
LOT-0012
DURVALUMABUM CONC. PT. SOL. PERF. 50 MG / ML - 2,4 ML CONC (120 MG)
DURVALUMABUM CONC. PT. SOL. PERF. 50 MG / ML - 2,4 ML CONC (120 MG) cantitate minima acord cadru 10 cantitate maxima acord cadru 50
RON 103.4k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Selection criteria
Framework maximum value
Procurement Details
- Publication date
- 02 Jul 2026
- Notice type
- Contract notice — standard
- Languages
- Romanian
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 456794-2026
Documents (1)
Similar tenders
Poland – Various medicinal products – Dostawa różnych produktów leczniczych, produktów leczniczych dla układu nerwowego, środków leczniczych dla układu oddechowego, produktów leczniczych dla krwi, organów krwiotwórczych oraz układu krążenia, produktów leczniczych dla przewodu pokarmowego i metabolizmu, środków immunosupresyjnych, środków przeciwnowotworowych i immunomodulacyjnych (w tym produktów stosowanych w ramach programów ....
Czechia – Antineoplastic and immunomodulating agents – LP s obsahem lorlatinibu 2026
Slovakia – Antineoplastic and immunomodulating agents – Antineoplastické a imunomodulačné činidlá
Romania – Pharmaceutical products – Furnizare MEDICAMENTE DIVERSE si PNS
Poland – Immunoglobulins – Dostawy produktów leczniczych, wyrobów medycznych oraz substancji do receptury
Slovakia – Antineoplastic and immunomodulating agents – Antineoplastické a imunomodulačné činidlá ( bežné )
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Risk factors
Submission deadline in 9 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications